Source comparison
CJC-1295 vs Other Growth Hormone Secretagogues: Sleep Quality Comparison
CJC-1295 is one of several peptides that stimulate growth hormone release, but its effects on sleep architecture differ meaningfully from alternatives like ipamorelin, GHRP-2, or MK 677 (ibutamoren). Understanding these differences is critical for selecting th
This comparison does not assign a generated winner or score.
- CJC-1295 is one of several peptides that stimulate growth hormone release, but its effects on sleep architecture differ meaningfully from alternatives like ipamorelin, GHRP-2, or MK 677 (ibutamoren). Understanding these differences is critical for selecting the right compound for sleep-focused research.
- CJC-1295 (with DAC)
- GHRH receptor agonist
- 6–8 days
- Increases slow-wave sleep duration by 30–40%; deepens Stage 3 NREM
- Sustained, amplified nocturnal pulse (90–120 min duration)
- Best for sustained slow-wave sleep enhancement. Works with natural circadian rhythm
- Ipamorelin
- Ghrelin receptor agonist (selective)
- ~2 hours
- Minimal direct effect on sleep stages; acute GH spike without sustained elevation
- Sharp, brief pulse (20–30 min). Mimics natural pulsatility
- Ideal for acute GH release; less effective for sleep quality vs CJC-1295
- GHRP-2
- Ghrelin receptor agonist (non-selective)
- ~30 minutes
- Can increase hunger and cortisol, potentially disrupting sleep onset
- Acute pulse with cortisol co-release
- Not recommended for evening use. Cortisol spike counterproductive for sleep
- MK 677 (Ibutamoren)
- Oral ghrelin mimetic
- 24 hours
- Increases REM sleep but less pronounced effect on slow-wave vs CJC-1295
- Chronic elevation of baseline GH and IGF-1
- Oral convenience; REM benefits but less Stage 3 deepening than CJC-1295
- CJC-1295 + Ipamorelin
- Dual GHRH + ghrelin agonism
- Variable (DAC sustains CJC)
- Combines sustained pulse duration with acute amplitude increase
- Extended, high-amplitude pulse
- Synergistic for both GH output and slow-wave sleep. Most robust combination
- The key differentiator is pulse duration vs amplitude. Ipamorelin produces a sharp, high-amplitude GH spike that mimics the body's natural pulsatile release. Useful for metabolic research but less impactful on sleep architecture because the pulse is too brief to sustain deep sleep. CJC-1295 extends the pulse without necessarily increasing peak amplitude as much, which is what correlates with longer time in slow-wave sleep. Combining the two (as in CJC1295 Ipamorelin 5MG 5MG) produces both extended duration and higher amplitude. The most favourable profile for sleep quality research.
- MK 677 deserves separate mention because it's orally bioavailable and produces chronic GH elevation rather than pulsatile release. While it does increase REM sleep and has been studied for sleep disorders, its effect on slow-wave sleep is less pronounced than CJC-1295's. Additionally, MK 677 significantly increases appetite (via ghrelin mimicry), which can interfere with evening protocols if users eat large meals close to bedtime.